Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa

ClinicalTrials.gov ID: NCT04092452

Public ClinicalTrials.gov record NCT04092452. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 4:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 2A, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 16-WEEK STUDY EVALUATING THE SAFETY AND EFFICACY OF PF-06650833, PF-06700841, AND PF-06826647 IN ADULTS WITH MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study with 3 kinase inhibitors (PF 06650833, PF 06700841 and PF 06826647) in participants with moderate to severe HS. The study will have a maximum duration of approximately 26 weeks. This includes an up to 6-week Screening Period, a 16 week Dosing Period and a 4 week Follow up Period.

Study identification

NCT ID
NCT04092452
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
194 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2, 2019 (Actual)
Primary completion
Jan 10, 2022 (Actual)
Completion
Jan 10, 2022 (Actual)
Last update posted
Jun 15, 2023

2019 – 2022

United States locations

U.S. sites
63
U.S. states
23
U.S. cities
45
Facility City State ZIP Site status
The University Of Alabama At Birmingham Birmingham Alabama 35233 —
The University of Alabama at Birmingham Hospital Outreach Lab Birmingham Alabama 35249 —
The University of Alabama at Birmingham Investigation Drug Services Pharmacy Birmingham Alabama 35249 —
The University of Alabama at Birmingham Birmingham Alabama 35294 —
Mayo Clinic Scottsdale Arizona 85259 —
Center for Dermatology Clinical Research, Inc. Fremont California 94538 —
Pacific Clinical Trials Long Beach California 90806 —
Keck School of Medicine of University of Southern California Los Angeles California 90033 —
UCSF Dermatology Clinic San Francisco California 94115 —
University of California San Francisco San Francisco California 94115 —
UCSF Psoriasis and Skin Treatment Center San Francisco California 94118 —
Clinical Science Institute Santa Monica California 90404 —
New England Research Associates, LLC Bridgeport Connecticut 06606 —
Dermatology Physicians of Connecticut Shelton Connecticut 06484 —
Total Dermatology Care Center Jacksonville Florida 32204 —
Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
Olympian Clinical Research Largo Office Largo Florida 33770 —
University of Miami Hospital Miami Florida 33125 —
Tory Sullivan MD PA North Miami Beach Florida 33162 —
Renstar Medical Research Ocala Florida 34470 —
MidState Skin Institute Ocala Florida 34471 —
Renstar Medical Research Ocala Florida 34471 —
Park Avenue Dermatology Orange Park Florida 32073 —
Leavitt Medical Associates of Florida d/b/a Ameriderm Research Ormond Beach Florida 32174 —
Riverchase Dermatology and Cosmetic Surgery Pembroke Pines Florida 33028 —
ForCare Clinical Research Tampa Florida 33613 —
Alliance Clinical Research of Tampa Tampa Florida 33615 —
MedaPhase Inc. Newnan Georgia 30263 —
Advanced Medical Research PC Sandy Springs Georgia 30328 —
Georgia Skin Cancer and Aesthetic Dermatology Watkinsville Georgia 30677 —
NorthShore University HealthSystem Dermatology Clinic Skokie Illinois 60077 —
Ds Research Clarksville Indiana 47129 —
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46250 —
DS Research Louisville Kentucky 40241 —
Boston Medical Center Boston Massachusetts 02118 —
Boston University General Clinical Research Unit Boston Massachusetts 02118 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Wayne State University / Integrative Biosciences Center Detroit Michigan 48202 —
Revival Research Institute, LLC Troy Michigan 48084 —
Clinical Research Unit Minneapolis Minnesota 55455 —
Lillihei Clinical Research Unit Minneapolis Minnesota 55455 —
University of Minnesota Department of Dermatology Minneapolis Minnesota 55455 —
MediSearch Clinical Trials Saint Joseph Missouri 64506 —
Saint Louis University - Department of Dermatology St Louis Missouri 63110 —
Skin Specialists PC Omaha Nebraska 68144 —
J Woodson Clinical Studies Group Henderson Nevada 89052 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
Vital Prospects Clinical Research Institute Tulsa Oklahoma 74136 —
Penn State Health Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
Penn State Health Radiology - University Physician Center Hershey Pennsylvania 17033 —
Paddington Testing Company, Inc Philadelphia Pennsylvania 19103 —
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 —
Thomas Jefferson University Philadelphia Pennsylvania 19107 —
Dermatology and Skin Cancer Consultants Humboldt Tennessee 38343 —
Clinical Research Solutions Jackson Tennessee 38305 —
Dermatology and Skin Cancer Consultants Jackson Tennessee 38305 —
Arlington Research Center Arlington Texas 76011 —
Austin Institute for Clinical Research, Inc. Pflugerville Texas 78660 —
University of Utah MidValley Dermatology Murray Utah 84107 —
Virginia Commonwealth University Medical Center Richmond Virginia 23298 —
Bellevue Dermatology Clinical Research Center Bellevue Washington 98004 —
Bellevue Dermatology Clinic Bellevue Washington 98004 —
Dermatology Associates of Seattle Seattle Washington 98101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04092452, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 15, 2023 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04092452 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →